UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000032982
Receipt No. R000037609
Official scientific title of the study Analyses of the skin molecules in patients with Parkinson's disease.
Date of disclosure of the study information 2018/06/20
Last modified on 2018/12/26 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Analyses of the skin molecules in patients with Parkinson's disease.
Title of the study (Brief title) Analyses of the skin molecules in patients with Parkinson's disease.
Region
Japan

Condition
Condition Parkinson's disease
Classification by specialty
Neurology Dermatology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Evaluation of the skin molecules in patients with Parkinson's disease.
Basic objectives2 Others
Basic objectives -Others The observational study of the relationship between skin molecules and states of Parkinson's disease.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The relationship between skin molecules and states of Parkinson's disease.
Key secondary outcomes The relationship of the molecules between skin and blood.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
89 years-old >=
Gender Male and Female
Key inclusion criteria 1.Panelists with sporadic Parkinson's disease (Hoehn & Yahr stage I or II).
2.Japanese male panelists who are 20-89 years old.
3.Panelists who agree to have their typical daily routines.
Key exclusion criteria 1.Panelists who use the drug for the treatment of Parkinson's disease
2.Panelists who have the type I or II diabetes.
3.Panelists who have the malignant tumors or history of them.
4.Panelists who have the skin diseases, such as atopic dermatitis, acne vulgaris, and psoriasis vulgaris.
5.Panelists who have the infectious diseases, such as HIV, HCV, HIV, and syphilis.
6.Panelists who use the antibiotics within 2 weeks before participation in this study.
7.Panelists who use the prescription drugs having any effects to this study.
8.Panelists who use the prescription topical agents on the face
Target sample size 100

Research contact person
Name of lead principal investigator Takayoshi Inoue
Organization Kao Corporation
Division name Biological Science Research
Address 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN
TEL +81-285-68-7498
Email inoue.takayoshi@kao.com

Public contact
Name of contact person Yuya Uehara
Organization Kao Corporation
Division name Biological Science Research
Address 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN
TEL +81-285-68-7461
Homepage URL
Email uehara.yuuya@kao.com

Sponsor
Institute Kao Corporation
Institute
Department

Funding Source
Organization Kao Corporation
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor Juntendo University
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 順天堂大学医学部付属順天堂医院(東京都)

Other administrative information
Date of disclosure of the study information
2018 Year 06 Month 20 Day

Progress
Recruitment status Completed
Date of protocol fixation
2018 Year 06 Month 20 Day
Anticipated trial start date
2018 Year 06 Month 21 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information The observational study of the relationship between skin molecules and states of Parkinson's disease.

Management information
Registered date
2018 Year 06 Month 14 Day
Last modified on
2018 Year 12 Month 26 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037609